Arginine hypomethylation-mediated proteasomal degradation of histone H4-an early biomarker of cellular senescence
Arginine hypomethylation-mediated proteasomal degradation of histone H4-an early biomarker of cellular senescence
复制标题
精氨酸低甲基化介导的组蛋白 H4 的蛋白酶体降解——细胞衰老的早期生物标志物
DOI:
10.1038/s41418-020-0562-8
复制
发表时间:
2020-05-23
影响因子:
12.4
通讯作者:
Zhang, Yu
中科院分区:
文献类型:
--
作者:
Lin, Cong;Li, Hongxin;Zhang, Yu
Senescence is accompanied with histones level alteration; however, the roles and the mechanisms of histone reduction in cellular senescence are largely unknown. Protein arginine methyltransferase 1 (PRMT1) is the major enzyme that generates monomethyl and asymmetrical dimethyl arginine. Here we showed that abrogation of PRMT1-mediated senescence was accompanied with decreasing histone H4 level. Consistently, under multiple classic senescence models, H4 decreasing was also been found prior to the other 3 core histones. Noticeably, asymmetric demethylation of histone H4 at arginine 3 (H4R3me2as), catalyzed by PRMT1, was decreased prior to histone H4. In addition, we showed that the PRMT1-mediated H4R3me2as maintained H4 stability. Reduction of H4R3me2as level increased the interaction between proteasome activator PA200 and histone H4, which catalyzes the poly-ubiquitin-independent degradation of H4. Moreover, H4 degradation promoted nucleosome decomposition, resulting in increased senescence-associated genes transcription. Significantly, H4 was restored by 3 well-informed anti-aging drugs (metformin, rapamycin, and resveratrol) much earlier than other senescence markers detected under H2O2-induced senescence. Thus, we uncovered a novel function of H4R3me2as in modulation of cellular senescence via regulating H4 stability. This finding also points to the value of histone H4 as a senescence indicator and a potential anti-aging drug screening marker.